In vivo degradation and biological safety of microporous vacuum polysaccharide hemostatic microspheres

doi:10.3969/j.issn.2095-4344.2015.52.015

Abstract

Abstract:

BACKGROUND: Microporous vacuum polysaccharide hemostatic microspheres are derived from degenerated potato plant starch and prepared through special processing. It is an ideal absorbable polymer styptic material with independent intellectual property rights. OBJECTIVE: To observe the degradation of microporous vacuum polysaccharide hemostatic microspheres and detect the safety indicators of body fluids by implanting microporous vacuum polysaccharide hemostatic microspheres in rats.
METHODS: 0.1-0.2 g microporous vacuum polysaccharide hemostatic microspheres were implanted subcutaneously on the left side of the spine in 12 rats. At the 1st, 3rd, 7th and 14th days after implantation,
the degradation of microporous vacuum polysaccharide hemostatic microspheres in the tissue was observed. Another 15 rats were selected, of which 5 rats were taken as the control group and fed normally, and 10 rats were subjected to anesthesia. Two incisions were made on both sides of the spine, about 5 cm, deep into the muscular layer of 0.3 cm. The right amount of hemostatic microspheres were sprayed on the incisions and covered the entire wound, then the incisions were sutured. The 10 rats were raised normally for 14 days. The various indicators of body fluids such as appearance features, activities, excretion, feeding were detected. Finally, the rats were dissected, and the gross morphology and color changes of main organs were observed.
RESULTS AND CONCLUSIONS: The microporous vacuum polysaccharide hemostatic microspheres buried in rats were completely degraded and absorbed within 7 days. After spraying the right amount of microporous vacuum polysaccharide hemostatic microspheres on the incision, the vital signs and biochemical indicators, such as blood and urine tests were all normal. The gross morphology and color of main organs such as liver, spleen, brain and kidney were not found significant anomalies. These results demonstrate that microporous vacuum polysaccharide hemostatic microspheres can be degraded into monosaccharide by amylase and can be completely degraded and absorbed within 7 days, without any side effects to tissues and organs.

中国组织工程研究杂志出版内容重点：生物材料；骨生物材料; 口腔生物材料; 纳米材料; 缓释材料; 材料相容性；组织工程

CLC Number:

R318

Du Bao-tang, Shi Yue, He Yuan-qing, Yin Wen-jing, Wang Ying. In vivo degradation and biological safety of microporous vacuum polysaccharide hemostatic microspheres[J]. Chinese Journal of Tissue Engineering Research, 2015, 19(52): 8444-8449.

Figures/Tables 4

References

[1] Sauai A, Moore FA,Moore EE, et al. Epidemiology of trauma deaths: A reassessment. J Trauma. 1995;38(2):185-193.

[2] Champion HR, Bellamy RF, Roberts CP, et al. A profile of combat injury. J Trauma. 2003;54(5):S13-S19.

[3] Stewart RM, Myers JG, Dent DL, et al. Seven humdred fifty-three consecutive deaths in a level 1 trauma center: The argument for injury prevention. J Trauma. 2003;54(1):66-71.

[4] Kauvar DS, Lefering R, Wade CE. Impact of hemorrhage on trauma outcome: an overview of epidemiology, clinical presentations, and therapeutic considerations. J Trauma. 2006;60(6 suppl):S3-S11.

[5] 李钒,田丰,刘长军,等.急救止血材料的研究进展[J].材料导报, 2013,27(3):70-73.

[6] 史跃,杜宝堂,何远清,等.多微孔多聚糖止血粉应用于软组织创伤出血[J].中国组织工程研究,2014,18(3):406-411.

[7] 李东红,高华,李鹏熙,等.几种止血材料对兔实质脏器创伤止血性能的比较[J].创伤外科杂志,2012,14(5):435-435.

[8] Emilia M, Luca S, Francesca B, et al. Topical hemostatic agents in surgical practice. Transfus Apher Sci. 2011; 45(3): 305-311.

[9] Kim IY, Eichel L, Edwards R, et al. Effects of commonly used hemostatic agents ofn the porcine collecting system. J Endourol. 2007;21(6):652-654.

[10] 张少锋,洪加源.医用生物可吸收止血材料的研究现状与临床应用[J].中国组织工程研究,2012,16(21):3941-3944.

[11] 熊绪琼,梅昕,马凤森.多糖类可吸收止血材料的研究进展[J].中华创伤杂志,2015,31(6):571-574.

[12] 武岳,王冰,姚天明.新型创伤急救止血材料的研究进展[J].中国临床实用医学,2014,5(4):78-80.

[13] 中华人民共和国科学技术部.关于善待实验动物的指导性意见. 2006-09-30.

[14] Granville-Chapman J, Jacobs N, Midwinter MJ. Per-hospital haemostatic dressings: a systematic review. Injury. 2011; 42(5): 477-459.

[15] Gruen RL, Brohi K, Schreiber M, et al. Haemorrhage control in severely injured patients. Lancet. 2012;380(9847): 1099-1108.

[16] Seyedenejad H, Imani N, Jamieson T, et al. Topical haemostatic agents. British J Surg. 2008;95(10):1197-1225.

[17] Schwartz M, Madariaga J, Hirose R, et al. Comparison of a new fibrin sealant with standard topical hemostatic agents. Arch Surg. 2004;139(11):1148-1154.

[18] Spotnitz WD. Fibrin sealabt: past, present, and future: a brief review. World J Serg. 2010,34(4):632-634.

[19] Jackson MR. Fibrin sealants in surgical practice: an overview. Am J Surg. 2001;182(2 suppl):1S-7S.

[20] Palm MD, Altman JS. Topical hemostatic agents: a review. Dermatol Surg. 2008;34(4):431-445.

[21] Achneck HE, Sileshi B, Jamiolkowski RM, et al. A comprehensive review of topical hemostatic agents efficacy and recommendations for use. Ann Surg. 2010;251(2): 217-228.

[22] 余雪松,黄赤兵,张艮甫.局部止血材料临床应用现状[J].创伤外科杂志,2008,10(6):565-567.

[23] Alam HB, Burris D, DaCorta JA, et al. Hemorrhage Control in the Battlefield: Role of New Hemostatic Agents. Mil Med. 2005;170(1):63-69.

[24] 刘亚平,侯春林,顾其胜,等.可生物降解止血粉的制备及其止血性能[J].中国重建外科杂志,2007,21(8):829-832.

[25] 杜宝堂.利用植物淀粉经交叉乳化制备术中止血材料的方法:中国,201110073208.2[P].2013-07-17.

[26] 史跃,沈烈,杜宝堂,等.微孔多聚糖止血球组织吸收实验研究[J].医疗卫生装备,2014,35(8):15-18.

[27] Tschan CA, Nie M, Schwandt E, et al. Safety and efficacy of microporous polysaccharide hemospheres in neurosurgery. Neurosurgery. 2011;69(1 suppl operative):49-62.

[28] 牛雯,刘毅,刘曼玲.一种可吸收止血材料的生物降解研究[J].中国新药杂志,2012,19(4):336-339.

[29] 王勇,陆伟.体内可吸收止血材料研究及临床应用[J].生物医学工程杂志,2009,2(4):922-925.

[30] 张华.甲状腺手术应用泰绫150例探讨[J].中国医药导报, 2009, 6(19):207-209.

[31] Azevedo C, Marques M, Bombana A. Cytotoxic effects of cyanoacrylates used as retrograde filling materials: An in vitroanalysis. Pesqui Odontol Bras. 2003;17(2):113-118.

[32] Yi KI, Louis E, Robert E, et al. Effects of commonly used hemostatic agents on the porcine collecting system. J Endourol. 2007;21(6):652-654.

[33] Johan B, Pentti T. Blood protein adsorption onto chitosan. Biomaterials. 2002;23(12):2561-2568.

[34] Ishihara M. Photocrosslinkable chitosan as a dressing for wound occlusion and accelerator in healing process. Bomaterials. 2002;23(3):833-840.

[35] Tsuyoshi S. Locak hemostatic effects of mirocrystalling partially deacetylated chitin hydrochloride. J Biomed Mater Res. 2000;49(2):225-232.